AMRX Earnings

Quarterly EPS
$0.00
Q3 2024
$-0.10
Q4 2024
$0.04
Q1 2025
$0.07
Q2 2025
$0.01
Q3 2025
$0.11
Q4 2025
$0.20
Q1 2026
$0.18
Q2 2026
Latest Revenue796.2M
Latest Net Income69.6M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.18796.2M69.6M+9.9%+157.1%
Q1 2026$0.20722.5M78.0M+3.9%+400.0%
Q4 2025$0.11814.3M49.6M+11.5%+210.0%
Q3 2025$0.01784.5M18.1M+11.7%
Q2 2025$0.07724.5M35.6M+3.2%+250.0%
Q1 2025$0.04695.4M24.6M+5.5%+113.3%
Q4 2024-$0.10730.5M-20742000+18.4%+75.0%
Q3 2024$0.00702.5M11.8M+13.3%-100.0%
Q2 2024$0.02701.8M16.8M
Q1 2024-$0.30659.2M-81678000
Q4 2023-$0.40617.0M-93344000
Q3 2023$0.06620.0M25.0M
Amneal Pharmaceuticals (AMRX) — Earnings